Folic acid fortification of wheat flour: A cost-effective public health intervention to prevent birth defects in Europe

Nutrition Bulletin

Volumn 38, Issue 2, 2013, Pages 201-209

  Pachón, Helena ^a,b   Kancherla, V ^b   Handforth, B ^a   Tyler, V ^c   Bauwens, L ^d  

^a Mailstop: 1599 001 1BX (SPH: Global Health)   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNICEF   (United States)

^d International Federation for Spina Bifida and Hydrocephalus   (Belgium)

Author keywords

Folate; Food based approaches; Mandatory fortification; Neural tube defects; Prevention; Spina bifida

Indexed keywords

EID: 84880939992     PISSN: 14719827     EISSN: 14673010     Source Type: Journal    
DOI: 10.1111/nbu.12023     Document Type: Review

References (78)

1. BCN, FEC & CSC (Better Care Network, Family for Every Child & Consortium for Street Children) et al. (2012) Protect my future: the links between child protection and health and survival. Available at: http://www.familyforeverychild.org/sites/default/files/resources/Child%20protection%20and%20health%20and%20survival.pdf (accessed 1 February 2013).
2. Bellin MH, Bentley KJ, & Sawin KJ (2009) Factors associated with the psychological and behavioral adjustment of siblings of youths with spina bifida. Families, Systems, & Health: The Journal of Collaborative Family Healthcare 27: 1-15.
3. Blencowe H, Cousens S, Modell B et al. (2010) Folic acid to reduce neonatal mortality from neural tube disorders. International Journal of Epidemiology 39: i110-i121.
4. Bol KA, Collins JS, & Kirby RS (2006) Survival of infants with neural tube defects in the presence of folic acid fortification. Pediatrics 117: 803-13.
5. Botto LD, Lisi A, & Robert-8Gnansia E (2005) International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working?. British Medical Journal 330: 571.
6. Bower C, & Stanley FJ (2004) Case for mandatory fortification of food with folate in Australia, for the prevention of neural tube defects. Birth Defects Research Part A: Clinical and Molecular Teratology 70: 842-3.
7. Bowman RM, McLone DG, Grant JA et al. (2001) Spina bifida outcome: a 25-year prospective. Pediatric Neurosurgery 34: 114- 20.
8. Boyd PA, Haeusler M, Barisic I et al. (2011) Paper 1: the EUROCAT network-organization and processes. Birth Defects Research Part A: Clinical and Molecular Teratology 91: S2-S15.
9. Brough L, Rees GA, Crawford MA et al. (2009) Social and ethnic differences in folic acid use during preconception and early pregnancy in the UK: effect on maternal folate status. Journal of Human Nutrition, & Dietetics 22: 100-7.
10. Brown RD, Langshaw MR, Uhr EJ et al. (2011) The impact of mandatory fortification of flour with folic acid on the blood folate levels of an Australian population. Medical Journal of Australia 194: 65-7.
11. Busby A, Armstrong B, Dolk H et al. (2005) Preventing neural tube defects in Europe: a missed opportunity. Reproductive Toxicology 20: 393-402.
12. Campbell LR, Dayton DH, & Sohal GS (1986) Neural tube defects: a review of human and animal studies on the etiology of neural tube defects. Teratology 34: 171-87.
13. Castillo-Lancellotti C, Tur JA, & Uauy R (2013) Impact of folic acid fortification of flour on neural tube defects: a systematic review. Public Health Nutrition 16: 901-11.
14. CDC (Centers for Disease Control, & Prevention) (2007) Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects -United States, 2003. MMWR. Morbidity, & Mortality Weekly Report 56: 25-9.
15. CG (Canada Gazette) Canada Gazette Part II (1998) Statutory instruments 1998, SOR/98-549 to 552, pp. 3028-33. Available at: http://gazette.gc.ca/archives/p2/1998/1998-11-25/pdf/g2-13224.pdf (accessed 17 December 2012).
16. Clarke R, Halsey J, & Lewington S (2010) Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals. Archives of Internal Medicine 170: 1622-31.
17. Cortes F, Mellado C, & Pardo RA (2012) Wheat flour fortification with folic acid: changes in neural tube defects rates in Chile. American Journal of Genetics 158A: 1885-90.
18. Czeizel AE, & Dudas I (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. New England Journal of Medicine 327: 1832-5.
19. Daly LE, Kirke PN, Molloy A et al. (1995) Folate levels and neural tube defects: implications for prevention. Journal of the American Medical Association 274: 1698-702.
20. EC (European Commission) (2012) Community Register on the addition of vitamins and minerals and of certain other substances to foods. Available at: http://ec.europa.eu/food/food/labellingnutrition/vitamins/comm_reg_en.pdf (accessed 24 January 2013).
21. EP (Euro-Peristat) (2004) European perinatal health report. Available at: http://www.europeristat.com/reports/european-perinatalhealth-report.html (accessed 12 March 2013).
22. EPCEU (European Parliament, & the Council of the European Union) (2006) Regulation (EC) No 1925/2006, Official Journal of 20 December 2006, L 404/26.
23. EUROCAT (European Surveillance of Congenital Anomalies) (2009) Special report: prevention of neural tube defects by periconceptional folic acid supplementation in Europe -December 2009. Available at: http://www.eurocat-network.eu/pagecontent.aspx?pageid=115 (accessed 10 March 2013).
24. FFI (Flour Fortification Initiative) (2008) Executive Management Team Minutes (unpublished document).
25. FFI (Flour Fortification Initiative) (2013) Global progress. Available at: http://www.ffinetwork.org/global_progress/index.php (accessed 1 January 2013).
26. FOB (The Federation of Bakers) (2011) How bread is made. Fact sheet no. 7. Available at: http://www.bakersfederation.org.uk/images/pdfs/media-and-resources/how-bread-is-made.pdf (accessed 24 January 2013).
27. Frey L, & Hauser WA (2003) Epidemiology of neural tube defects. Epilepsia 44 (Suppl. 3): 4-13.
28. FSAI (Food Safety Authority of Ireland) (2008) Report of the Implementation Group on Folic Acid Food Fortification to the Department of Health and Children. Food Safety Authority of Ireland: Dublin.
29. Greenlees R, Neville A, Marie-Claude Addor M-C et al. (2011) Paper 6: EUROCAT member registries: organization and activities. Birth Defects Research Part A: Clinical and Molecular Teratology 91: S51-S100.
30. Grewal J, Carmichael SL, Song J et al. (2009) Neural tube defects: an analysis of neighbourhood-and individual-level socioeconomic characteristics. Paediatric, & Perinatal Epidemiology 23: 116-24.
31. Grosse SD, Waitzman NJ, Romano PS et al. (2005) Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health. American Journal of Public Health 95: 1917-22.
32. Hankey GJ, Eikelboom JW, Lees KR et al. (2012) Treatment with B vitamins and incidence of cancer in patients with previous stroke or transient ischemic attack: results of a randomized placebocontrolled trial. Stroke 43: 1572-7.
33. Heseker HB, Mason JB, Selhub J et al. (2009) Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid. British Journal of Nutrition 102: 173-80.
34. IF (International Federation for Spina Bifida, & Hydrocephalus), Bayer Health Care, & MediClara (2011) Act against Europe's most common birth defects: one year on. Available at: http://www.asbi.info/uploaded_files/attachments/201107211311262538/second_report_on_neural_tube_defect_prevention.pdf (accessed 29 November 2012).
35. IOM (Institute of Medicine) (1998) Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. National Academies Press: Washington DC.
36. Ireys HT, Anderson GF, Shaffer TJ et al. (1997) Expenditures for care of children with chronic illnesses enrolled in the Washington State Medicaid program, fiscal year 1993. Pediatrics 100: 197-204.
37. Jaquier M, Klein A, & Boltshauser E (2006) Spontaneous pregnancy outcome after prenatal diagnosis of anencephaly. British Journal of Obstetrics, & Gynaecology 113: 951-3.
38. Khoshnood B, Greenlees R, Loane M et al. (2011) Paper 2: EUROCAT public health indicators for congenital anomalies in Europe. Birth Defects Research Part A: Clinical, & Molecular Teratology 91: S16-S22.
39. Kim Y (2004) Will mandatory folic acid prevent or promote cancer?. The American Journal of Clinical Nutrition 80: 1123-8.
40. Lalor J, Begley CM, & Galavan E (2009) Recasting hope: a process of adaptation following fetal anomaly diagnosis. Social Science, & Medicine 68: 462-72.
41. Lawrence MA, Chai W, Kara R et al. (2009) Examination of selected national policies towards mandatory folic acid fortification. Nutrition Reviews 67 (Suppl. 1): S73-S78.
42. Llanos A, Hertrampf E, Cortes F et al. (2007) Cost-effectiveness of a folic acid fortification program in Chile. Health Policy 83: 295-303.
43. Mason J (2011) Unraveling the complex relationship between folate and cancer risk. Biofactors 37: 253-60.
44. Mills JL, Von Kohorn I, Conley MR et al. (2003) Low vitamin B-12 concentrations in patients without anemia: the effect of folic acid fortification of grain. American Journal of Clinical Nutrition 77: 1474-7.
45. MOD (March of Dimes) (2006) Global Report on Birth Defects: The Hidden Toll of Dying and Disabled Children. March of Dimes Birth Defects Foundation: White Plains, NY.
46. Montgomery SJ (2012) Flour fortification: overview and benefits to Europe. Presentation at the European Health Forum, Gastein, Austria. Available at: http://www.ffinetwork.org/about/calendar/2012/Documents%202012/GasteinOverview.pdf (accessed 24 January 2013).
47. MPI (Ministry for Primary Industries) (2012) Voluntary folic acid fortification monitoring and evaluation report. MPI Technical Paper No: 2012/01. MPI: Wellington.
48. MRC (Medical Research Council) Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 338: 131-7.
49. Nilsen RM, Vollset SE, Gjessing HK et al. (2006) Patterns and predictors of folic acid supplement use among pregnant women: the Norwegian mother and child cohort study. American Journal of Clinical Nutrition 84: 1134-41.
50. O'Connor A (2012) An overview of the role of bread in the UK diet. Nutrition Bulletin 37: 193-212.
51. Ouyang L, Grosse SD, Armour BS et al. (2007) Health care expenditures of children and adults with spina bifida in a privately insured U.S. population. Birth Defects Research Part A: Clinical, & Molecular Teratology 79: 552-8.
52. PA (Parliamentary Assembly) (2011) Preventive health care policies in the Council of Europe member states, Recommendation 1959. Available at: http://assembly.coe.int/ASP/Doc/XrefViewHTML.asp?FileID=17960&Language=EN (accessed 23 January 2013).
53. Pfeiffer CM, Schleicher RL, Johnson CL et al. (2012) Assessing vitamin status in large population surveys by measuring biomarkers and dietary intake -two case studies: folate and vitamin D. Food, & Nutrition Research 56: 5944.
54. Pitkin RM (2007) Folate and neural tube defects. American Journal of Clinical Nutrition 85: 285S-8S.
55. Rabovskaja V, Parkinson B, & Goodall S (2013) The costeffectiveness of mandatory folic acid fortification in Australia. Journal of Nutrition 143: 59-66.
56. Ray JG, Singh G, & Burrows RF (2004) Evidence for suboptimal use of periconceptional folic acid supplements globally. British Journal of Obstetrics, & Gynaecology 111: 399-408.
57. SACN (Scientific Advisory Committee on Nutrition) (2008) Paper for information: Briefing for review of SACN recommendations for mandatory fortification. Available at: http://www.sacn.gov.uk/pdfs/sacn_08_00.pdf (accessed 10 December 2012).
58. Safi J, Joyeux L, & Chalouhi GE (2012) Periconceptional folate deficiency and implications in neural tube defects. Journal of Pregnancy 2012: 1-9.
59. Sawin KJ, & Bellin MH (2010) Quality of life in individuals with spina bifida: a research update. Developmental Disabilities Research Reviews 16: 47-59.
60. Sayed AR, Bourne D, Pattinson R et al. (2008) Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Research Part A: Clinical, & Molecular Teratology 82: 211-6.
61. Suitor CW, & Bailey LB (2000) Dietary folate equivalents: interpretation and application. Journal of the American Dietetic Association 100: 88-94.
62. Tamura T, & Picciano MF (2006) Folate and human reproduction. American Journal of Clinical Nutrition 83: 993-1016.
63. Thurman AR, Clark MR, & Doncel GF (2011) Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies. Infectious Diseases in Obstetrics, & Gynecology 2011: 1-10.
64. Vollset SE, Clarke R, Lewington S et al. (2013) Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trails: meta-analyses of data on 50 000 individuals. Lancet 381: 1029-36.
65. Wang Y, Hu J, Druschel CM et al. (2011) Twenty-five-year survival of children with birth defects in New York State: a populationbased study. Birth Defects Research Part A: Clinical, & Molecular Teratology 91: 995-1003.
66. WHO, & CDC (World Health Organization, & Centers for Disease Control, & Prevention) (2012) WHO/CDC Technical Consultation: Optimal blood folate concentrations in women of reproductive age for prevention of neural tube defects. Available at: http://www.who.int/nutrition/events/2012_WHOandCDC_technicalconsultation_August/en/(accessed 2 April 2013).
67. WHO, & FAO (World Health Organization, & Food, & Agriculture Organization) (2006) Guidelines on Food Fortification with Micronutrients. WHO: Geneva.
68. WHO (World Health Organization) (2004) Vitamin and mineral requirements in human nutrition, second edition. Available at: http://www.who.int/nutrition/publications/micronutrients/9241546123/en/index.html (accessed 10 March 2013).
69. WHO (World Health Organization) (2007) Prevention of neural tube defects: Integrated management of pregnancy and childbirth. Standards for maternal and neonatal care. Available at: http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/neural_tube_defects.pdf (accessed 5 December 2012).
70. WHO (World Health Organization) (2012) Serum and red blood cell folate concentrations for assessing folate status in populations. Vitamin and Mineral Nutrition Information System. WHO: Geneva. Available at: http://apps.who.int/iris/bitstream/10665/75584/1/WHO_NMH_NHD_EPG_12.1_eng.pdf (accessed 23 January 2013).
71. WHO (World Health Organization) (2013) Where we work: our work in European countries. Available at: http://www.euro.who.int/en/where-we-work (accessed 1 February 2013).
72. WHO, FAO, UNICEF et al. (World Health Organization, Food, & Agriculture Organization, UNICEF et al.) (2009) Recommendations on wheat and maize flour fortification. Meeting Report: Interim Consensus Statement. WHO: Geneva.
73. Wien TN, Pike E, Wisløff T et al. (2012) Cancer risk with folic acid supplements: a systematic review and meta-analysis. British Medical Journal Open 2: e000653.
74. Yang Q, Cogswell ME, Hamner HC et al. (2010) Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003-2006. American Journal of Clinical Nutrition 91: 64-72.
75. Yeung LF, Cogswell ME, Carriquiry AL et al. (2011) Contributions of enriched cereal-grain products, ready-to-eat cereals, and supplements to folic acid and vitamin B-12 usual intake and folate and vitamin B-12 status in US children: National Health and Nutrition Examination Survey (NHANES), 2003-2006. American Journal of Clinical Nutrition 93: 172-85.
76. Yi Y, Lindemann M, Colligs A et al. (2011) Economic burden of neural tube defects and impact of prevention with folic acid: a literature review. European Journal of Pediatrics 170: 1391-400.
77. Young NL, Steele C, Fehlings D et al. (2005) Use of health care among adults with chronic and complex physical disabilities of childhood. Disability, & Rehabilitation 27: 1455-60.
78. Zimmerman S (2011) Fifteen years of fortifying with folic acid: birth defects are reduced and healthcare expenditures are averted. Sight and Life 25: 54-9. Available at: http://www.sightandlife.org/fileadmin/data/Magazine/2011/25_3_2011/views_15_years_of_fortifying_with_folic_acid.pdf (accessed 10 March 2013).